NCT01968070View on ClinicalTrials.gov

A Study of LY3127760 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

LY3127760

Administered orally

DRUG

Celecoxib

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

47710

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01968070 - A Study of LY3127760 in Healthy Participants | Biotech Hunter | Biotech Hunter